Literature DB >> 10937650

Language functions in patients with multiple sclerosis.

K B Friend1, B M Rabin, L Groninger, R H Deluty, C Bever, L Grattan.   

Abstract

Few studies have demonstrated language impairment in patients with multiple sclerosis (MS) compared to healthy controls. The purpose of this investigation was to examine language functions, specifically naming, comprehension, and verbal fluency, in patients with MS and healthy controls to (1) determine if patients with MS demonstrate language impairment, and (2) provide clarification of MS-related language disturbance, particularly in patients with MS of differing courses. Results showed that both chronic-progressive and relapsing-remitting patients with MS performed significantly more poorly than controls on naming, aural comprehension, letter fluency, and category fluency, as well as other language-based cognitive measures. Chronic-progressive patients obtained significantly lower scores than relapsing-remitting patients on the latter three tests. The language disturbance in this MS sample may be partly explained by impairment in other verbal cognitive functions. These findings highlight the importance of assessing language abilities in patients with MS.

Entities:  

Mesh:

Year:  1999        PMID: 10937650     DOI: 10.1076/clin.13.1.78.1979

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  5 in total

1.  FAS and CFL forms of verbal fluency differ in difficulty: a meta-analytic study.

Authors:  Danielle Barry; Marsha E Bates; Erich Labouvie
Journal:  Appl Neuropsychol       Date:  2008

2.  Word-finding difficulty is a prevalent disease-related deficit in early multiple sclerosis.

Authors:  Rachel Brandstadter; Michelle Fabian; Victoria M Leavitt; Stephen Krieger; Anusha Yeshokumar; Ilana Katz Sand; Sylvia Klineova; Claire S Riley; Christina Lewis; Gabrielle Pelle; Fred D Lublin; Aaron E Miller; James F Sumowski
Journal:  Mult Scler       Date:  2019-11-19       Impact factor: 6.312

3.  Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis.

Authors:  R S Prakash; E M Snook; J M Lewis; R W Motl; A F Kramer
Journal:  Mult Scler       Date:  2008-08-13       Impact factor: 6.312

4.  Evaluating the feasibility and preliminary efficacy of a Cognitive Occupation-Based programme for people with Multiple Sclerosis (COB-MS): protocol for a feasibility cluster-randomised controlled trial.

Authors:  Christopher P Dwyer; Alberto Alvarez-Iglesias; Robert Joyce; Timothy J Counihan; Dympna Casey; Sinéad M Hynes
Journal:  Trials       Date:  2020-03-17       Impact factor: 2.279

5.  Naming error in multiple sclerosis patients: A pilot study in Isfahan, Iran.

Authors:  Fereshteh Shamsian; Roshanak Mehdipour Dastjerdi; Arian Kavosh; Fereshteh Ashtari
Journal:  J Res Med Sci       Date:  2019-12-23       Impact factor: 1.852

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.